Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04447469 |
|---|---|
| Brief Title: | Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation |
| First Submitted : | June 23, 2020 |
| First Submitted that Met QC Criteria : | June 24, 2020 |
| First Posted : | June 25, 2020 |
| Certification/Extension First Submitted : | September 21, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | September 21, 2022 |
| Certification/Extension First Posted : | September 28, 2022 |
| Last Update Submitted that Met QC Criteria : | September 21, 2022 |
| Last Update Posted : | September 28, 2022 |